Ezaki Glico Co., Ltd. (TSE:2206) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Shareholders might have noticed that Ezaki Glico Co., Ltd. (TSE:2206) filed its quarterly result this time last week. The early response was not positive, with shares down 3.7% to JP¥4,268 in the past week. Results look mixed - while revenue fell marginally short of analyst estimates at JP¥87b, statutory earnings were in line with expectations, at JP¥222 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Ezaki Glico after the latest results.

Check out our latest analysis for Ezaki Glico

Taking into account the latest results, the current consensus from Ezaki Glico's three analysts is for revenues of JP¥343.1b in 2025. This would reflect a modest 4.9% increase on its revenue over the past 12 months. Per-share earnings are expected to soar 31% to JP¥193. In the lead-up to this report, the analysts had been modelling revenues of JP¥342.8b and earnings per share (EPS) of JP¥194 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

The analysts reconfirmed their price target of JP¥3,700, showing that the business is executing well and in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Ezaki Glico at JP¥3,800 per share, while the most bearish prices it at JP¥3,600. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. For example, we noticed that Ezaki Glico's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 3.9% growth to the end of 2025 on an annualised basis. That is well above its historical decline of 1.8% a year over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 3.7% per year. So while Ezaki Glico's revenues are expected to improve, it seems that it is expected to grow at about the same rate as the overall industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. The consensus price target held steady at JP¥3,700, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Ezaki Glico going out to 2026, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Ezaki Glico , and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.